V2C-66504-34473 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-18
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Chills, Headache, Muscle or body aches · Be unable to work

Adult check-in
2020-12-19
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches · Be unable to work

Adult check-in
2020-12-20
Report sent to call center — days 1–6 daily, dose 1
Be unable to work

1 call case(s)
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Muscle or body aches

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-25
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-08
Survey response — day 21, dose 1
MedDRA: Diverticulitis, White blood cell count increased — Feeling: Good · Be unable to work

Free text: Diverticulitis and elevated wbc

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — day 21, dose 1
Be unable to work

1 call case(s)
2021-12-18
Survey response — 12 months, dose 1
MedDRA: Myelitis, Neuritis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Diagnosed with Post Covid Vaccine Neuritis/Myelitis

MedDRA releases: 2024-11 · check-in free text available
2021-12-18
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2021-12-21
Call successful
Other

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-19	priority 2/3
2020-12-20	priority 2/3
2021-01-08	priority 2/3
2021-12-18	Successful 2021-12-21	Other

Free text

Release 1 — day 21, dose 1

2021-01-08

Symptoms: Diverticulitis and elevated wbc

Release 10 — 12 months, dose 1

2021-12-18

Symptoms: Diagnosed with Post Covid Vaccine Neuritis/Myelitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Diverticulitis	✓	✓	✓
SD	Myelitis	·	·	✓
SD	Neuritis	·	·	✓
SD	White blood cell count increased	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release